Abstract
Technetium-99m hexamethylpropylene amine oxime (HMPAO) labelled leucocytes and indium-111 polyclonal immunoglobulin (IgG) were simultaneously injected into a group of 27 patients routinely referred for the investigation of inflammatory bowel disease (IBD). Ten-minute anterior abdomen and tail on detector views were obtained at 30 min, 4 h and 24 h p.i. of both tracers. The diagnosis of IBD was obtained in all cases by endoscopy with biopsy and/or surgery. Images were blindly evaluated by two experienced observers who only knew of the clinical suspicion of IBD. IBD was confirmed in 20 patients (12 with Crohn's disease and eight with ulcerative colitis). Sensitivity, specificity and accuracy were 100%, 85% and 96% respectively for labelled leucocytes and 70%, 85% and 74% for IgG. Both IgG and leucocyte scans were normal in six out of seven patients in whom a diagnosis of IBD was excluded; the remaining patient, with ischaemic colitis, was falsely positive with both agents. As far as disease extension is concerned, the IgG study localized 27 diseased segments, whereas 49 were seen with the leucocyte study. Eighty-four segments were normal and 25 showed tracer uptake with both agents. Twenty-four were positive only with the leucocyte study and two were positive only with the IgG study. Agreement between the agents was 80.7%. These results confirm that111In-human polyclonal scintigraphy is less sensitive than99mTc-HMPAO scintigraphy both for the diagnosis of IBD and in the evaluation of disease extension. Nevertheless, if leucocyte labelling is not available, labelled IgG can be used only for diagnostic purposes.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Fischman AJ, Rubin RH, Khaw BA, Callahan RJ, Wilkinson R, Keech F, Nedelman M, Dragotakes S, Kramer PB, LaMuraglia GM, Lind S, Strauss HW. Detection of acute inflammation with111In-labeled nonspecific polyclonal IgG.Semin Nucl Med 1988; 18:335–344.
Rubin RH, Fischman AJ, Callahan RJ, Khaw B, Keech F, Ahmad M, Wilkinson R, Strauss HW.111In-labeled nonspecific immunoglobulin scanning in the detection of focal infection.N Engl J Med 1989; 321:935–940.
Oyen WJG, Claessens RAMJ, van der Meer JWM, Corstens FHM. Detection of subacute infectious foci with indium-111-labeled autologous leucocytes and indium-111-labeled human nonspecific immunoglobulin G: a prospective comparative study.J Nucl Med 1991; 32:1854–1860.
Datz FL, Anderson CE, Ahluwalia R, Whiting JH, Gabor FV, Morton KA, Christian PE, Crebs K, Neptune M, Rauh DA. The efficacy of indium-111-polyclonal IgG for the detection of infection and inflammation.J Nucl Med 1994; 35:74–83.
Oyen WJG, van der Horn JR, Claessens RAMJ, Slooff TJJH, van der Meer JWM, Corstens FHM. Diagnosis of bone, joint, and joint prothesis infections with In-111-labeled nonspecific human immunoglobulin G scintigraphy.Radiology 1992; 182:195–199.
Berná LI, Torres G, Diez C, Estorch M, Martinez-Duncker D, Carrió I. Technetium-99m human polyclonal immunoglobulin G studies and conventional bone scans to detect active joint inflammation in chronic rheumatoid arthritis.Eur J Nucl Med 1992; 19:173–176.
Rubin RH, Fischman AJ. The use of radiolabeled nonspecific immunoglobulin in the detection of focal inflammation.Semin Nucl Med 1994; 24:169–179.
Buscombe J R, Lui D, Ensing G, de Jong R, Ell PJ. 99mTc-human immunoglobulin (HIG) — first results of a new agent for the localization of infection and inflammation.Eur J Nucl Med 1990; 16:649–655.
Arndt JW, van der Sluys Veer, Blok D, Griffioen G, Verspaget HW, Salvador Peña A, Lamers CBHW, Pauwels EKJ. A prospective comparision of 99mTc-labeled polyclonal human immunoglobulin and111In granulocytes for localization of inflammatory bowel disease.Acta Radiol 1992; 33:140–144.
Hebbard GS, Salehi N, Gibson P R, Lichtenstein M, Andrews JT.99mTc-labelled IgG scanning does not predict the distribution of intestinal inflammation in patients with inflammatory bowel disease.Nucl Med Commun 1992; 13:336–341.
Stavraka A, Malas E, Trapali X, Voliotopoulos B, Fronistas O, Giougi A, Yannacopoulos B, Limouris GS. Tc99m labelled human immunoglobulin in the detection of intestinal inflammatory disease.Eur J Nucl Med 1992; 19:685.
Martin-Comin J, Moragas M, Daumal J, Lomeña F, Roca M, Catafau A, Prat L, Bonnin D, Piera C. Inflammatory bowel disease with99mTc-HMPAO labelled leucocytes scintigraphy. In: Sinzinger H, Thakur ML, eds.Radiolabelled cellular blood elements. New York: Wiley-Liss; 1990:165–172.
Roca M, Mora J, Prat ML, Daumal J, De La Fuente C, Martin-Comin J. Marcaje de leucocitos con Tc-99m-HMPAO. Estudio metologico.Rev Esp Med Nuclear 1989; 3:3–7.
Roca M, Carrió I, Prat L, Blasi J, Ferrer I, Mora J, Martin-Comin J.111In labeling of human IgG using DTPA-IgG Kit. NATO ASI Series. Edited by Martin-Comin J, et al. 1994; 262:61–65.
Ybern A, Martin-Comin J, Giné JJ, Casanovas T, Villa R, Gassull MA.111In-oxine-labelled autologous leucocytes in inflammatory bowel disease: new scintigraphy activity index.Eur J Nucl Med 1986; 11:341–344.
Peters AM, Danpure HJ, Osman S, Hawker RJ, Henderson BL, Hodgson HJ, Kelly JD, Neirinckx RD. Clinical experience with 99mTc-hexamethylpropylene-amineoxime for labelling leucocytes and imaging inflammation.Lancet 1986; 25:946–949.
Roddie ME, Peters AM, Danpure HJ, Osman S, Henderson BL, Lavender JP, Carroll MJ, Neirinckx RD, Kelly JD. Inflammation: imaging with Tc-99m HMPAO-labeled leukocytes.Radiology 1988; 166:767–772.
Schölmerich J, Schmidt E, Schümichen C, Billmann P, Schmidt H, Gerok W. Scintigraphic assessment of bowel involvement and disease activity in Crohn's disease using technetium 99m-hexamethyl propylene amine oxine as leukocyte label.Gastroenterology 1988; 95:1287–1293.
Arndt JW, van der Sluys Veer A, Blok D, Griffioen G, Verspaget HW, Lamers CBHW, Pauwels KJ. Prospective comparative study of technetium-99m-WBC and indium-111-granulocytes for the examination of patients with inflammatory bowel disease.J Nucl Med 1993; 34:1052–1057.
Allan RA, Sladen GE, Bassingham S, Lazarus C, Clarke SEM, Fogelman I. Comparison of simultaneous99mTc-HMPAO and111In oxine labelled white cell scans in the assessment of inflammatory bowel disease.Eur J Nucl Med 1993; 20:195–200.
Corstens FHM, Claessens RAMH. Imaging inflammation with human polyclonal immunoglobulin: not looked for but discovered.Eur J Nucl Med 1992; 19:155–158.
Oyen WJG, Naber AHJ, Claessens RAMJ, van der Meer JWM, Corstens FHM. Imaging inflammatory bowel disease with In-111 labeled human nonspecific immunoglobulin G (In-111-IgG) scintigraphy.Eur J Nucl Med 1992; 19:604.
Prats E, Banzo J, Lopez Zaborras J, Gomollón F, Garcia Rey R, Freile E, Delgado M, Escalera T. Diagnostico, localización y valoración del grado de actividad de la enfermedad inflamatoria intestinal mediante leucocitos-HMPAO-99mTc.Rev Esp Med Nuclear 1990; 9:97–105.
Saverymuttu SH, Camilleri M, Rees H, Lavender JP, Hodgson HJF, Chadwick VS. Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease: a comparision with colonoscopy, histology, and fecal indium 111-granulocyte excretion.Gastroenterology 1986; 90:1121–1128.
Costa DC, Lui D, Ell PJ. White cells radiolabelled with111In and99mTc, a study of relative sensitivity and in vivo viability.Nucl Med Commun 1988; 9:725–731.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mairal, L., de Lima, P.A., Martin-Comin, J. et al. Simultaneous administration of111In-human immunoglobulin and99mTc-HMPAO labelled leucocytes in inflammatory bowel disease. Eur J Nucl Med 22, 664–670 (1995). https://doi.org/10.1007/BF01254568
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF01254568